Clovis Oncology Inc (CLVS.OQ)
CLVS.OQ on NASDAQ Stock Exchange Global Select Market
79.74USD
1 Aug 2013
79.74USD
1 Aug 2013
Price Change (% chg)
$1.86 (+2.39%)
$1.86 (+2.39%)
Prev Close
$77.88
$77.88
Open
$79.25
$79.25
Day's High
$81.75
$81.75
Day's Low
$79.18
$79.18
Volume
14,661
14,661
Avg. Vol
102,991
102,991
52-wk High
$86.29
$86.29
52-wk Low
$11.19
$11.19
About
Clovis Oncology, Inc. is a United States-based biopharmaceutical company. The Company develops anti-cancer agents. It focuses on acquiring, developing and commercializing anti-cancer agents in the United States, Europe and additional international markets. Its product candidates includes CO-101, a lipid-conjugated form of the... (more)
Overall
| Beta: | -- |
| Market Cap (Mil.): | $2,339.36 |
| Shares Outstanding (Mil.): | 30.04 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| CLVS.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 37.93 | 37.76 |
| EPS (TTM): | -2.73 | -- | -- |
| ROI: | -60.25 | 19.48 | 18.76 |
| ROE: | -60.46 | 20.17 | 19.59 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: ValuEngine, Inc.
|
$127.00
|
|
Provider: Zacks Investment Research Inc.
|
$12.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

